Mrv0541 05041406282D 21 22 0 0 1 0 999 V2000 1.3556 -0.1271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3556 0.6979 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.0701 1.1104 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 2.0701 1.9354 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.3556 2.3479 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.6411 1.9354 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.6284 1.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1435 0.8555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.1435 2.1904 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.6411 1.1104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.6411 -0.5396 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7845 0.6979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.7845 2.3479 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3556 3.1729 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.4534 1.5229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3984 0.0709 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1681 0.5547 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.3522 0.3352 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.7845 1.5229 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2.0701 2.7604 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.5549 2.7559 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 0 0 0 3 2 1 0 0 0 0 4 3 1 0 0 0 0 5 4 1 0 0 0 0 6 5 1 0 0 0 0 8 7 1 0 0 0 0 9 6 1 0 0 0 0 9 7 1 0 0 0 0 10 2 1 0 0 0 0 10 6 1 0 0 0 0 10 8 1 0 0 0 0 11 1 1 0 0 0 0 3 12 1 6 0 0 0 4 13 1 1 0 0 0 5 14 1 1 0 0 0 15 7 2 0 0 0 0 16 8 2 0 0 0 0 2 17 1 6 0 0 0 3 18 1 1 0 0 0 4 19 1 6 0 0 0 5 20 1 6 0 0 0 6 21 1 1 0 0 0 M END > DB02742 > drugbank > [H][C@]12NC(=O)C(=O)N1[C@]([H])(CO)[C@@]([H])(O)[C@]([H])(O)[C@]2([H])O > InChI=1S/C8H12N2O6/c11-1-2-3(12)4(13)5(14)6-9-7(15)8(16)10(2)6/h2-6,11-14H,1H2,(H,9,15)/t2-,3-,4+,5+,6+/m1/s1 > OIURYJWYVIAOCW-PQMKYFCFSA-N > C8H12N2O6 > 232.1907 > 232.069536126 > 6 > 28 > -0.0011569070808525243 > 20.32122454283561 > 1 > 5 > 0 > 0 > (5R,6R,7S,8R,8aS)-6,7,8-trihydroxy-5-(hydroxymethyl)-octahydroimidazo[1,2-a]pyridine-2,3-dione > -2.47 > -3.745120184 > -0.09 > 0 > 0 > 2 > 0 > 12.679862245512101 > 9.937172103150155 > -2.7973834143597296 > 130.33 > 47.42269999999999 > 1 > 1 > 1.90e+02 g/l > tetrahydrofolic acid > 0 > DB02742 > EXPT01973 > experimental > Kifunensine $$$$